Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-11

AUTHORS

Yixing Li, Paul D. Rosenblit

ABSTRACT

PURPOSE OF REVIEW: Mimetics and analogs that extend the half-life of native glucagon-like peptide-1 (GLP-1), i.e., glucagon-like peptide-1 receptor agonists (GLP-1 RAs), at therapeutic doses, are indicated as adjuncts to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus (T2DM). In patients with T2DM, GLP-1 RAs not only affect improvements in impaired beta cell and alpha cell function, suppress appetite, and induce weight loss but also possess multiple cardiovascular protective properties that potentially have a beneficial impact on atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality. RECENT FINDINGS: Required to demonstrate CV safety, compared to standard-of-care antidiabetic therapies, GLP-1 RAs have revealed statistically significant non-inferiority (p < 0.001), among CV outcome trials (CVOTs) thus far completed. Once-daily liraglutide and once-weekly semaglutide demonstrated significant superiority (p = 0.01 and p = 0.02, respectively), reducing 3-point composite major adverse cardiovascular events (MACE) in extreme risk secondary prevention adults with T2DM. Once-weekly exenatide demonstrated only a non-significant (p = 0.06) favorable trend for CV superiority, possibly due to in-trial mishaps, including placebo drop-ins with other CV protective medications. The short half-life lixisenatide was neutral (p = 0.81) in reducing MACE, most likely due to ineffective once-daily dosing. Structural differences among GLP-1 mimetics and analogs may explain potency differences in both A1C reduction and weight loss that may parallel important cardiovascular protective properties of the GLP-1 RA class. Significant superiority in reducing 3-point composite MACE in adults with T2DM with GLP-1 RAs has been limited to liraglutide and semaglutide. Careful attention to within-trial drop-in of cardioprotective antidiabetic agents assuring equipoise between placebo and investigational product groups might demonstrate significant MACE risk reduction with once-weekly exenatide. Maintenance of 24-h circulating levels, by an alternative administration method, may resurrect lixisenatide as a cardioprotective agent. Before a GLP-1 RA bioequivalence "class effect" claim for composite MACE risk reduction superiority can be fully discussed, we are obliged to wait for the pending results of CVOTs with other GLP-1 RAs, particularly albiglutide and dulaglutide, where steric hindrance may potentially inhibit full mimicry of pharmacologic GLP-1. More... »

PAGES

113

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11886-018-1051-2

DOI

http://dx.doi.org/10.1007/s11886-018-1051-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107253109

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30259238


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "West Anaheim Medical Center, Department of Medicine, OPTI-West, 3033 West Orange Ave, 92804, Anaheim, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Yixing", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, Irvine Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.417319.9", 
          "name": [
            "Dept. of Medicine, Div. Endocrinology, Diabetes & Metabolism, University California, Irvine, School of Medicine, Irvine, CA, USA", 
            "Diabetes Out-Patient Clinic, UCI Medical Center, Orange, CA, USA", 
            "Diabetes / Lipid Management & Research Center, 18821 Delaware St., Suite 202, 92648, Huntington Beach, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosenblit", 
        "givenName": "Paul D.", 
        "id": "sg:person.01151445632.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151445632.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bmj.321.7258.405", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000154862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.288.23.2998", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000553070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1607141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001940001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40265-015-0370-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004781251", 
          "https://doi.org/10.1007/s40265-015-0370-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db09-9028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004893088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2008.01.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007348653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1603827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010225149"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrendo.2012.140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011731640", 
          "https://doi.org/10.1038/nrendo.2012.140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circresaha.115.306249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014793790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circresaha.115.306249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014793790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)07019-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018881858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(14)60976-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019874547"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61267-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020847124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1107579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021736323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11883-003-0033-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022396275", 
          "https://doi.org/10.1007/s11883-003-0033-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.53.9.2492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022950121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-015-0343-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023022269", 
          "https://doi.org/10.1007/s40262-015-0343-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-015-0343-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023022269", 
          "https://doi.org/10.1007/s40262-015-0343-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-015-0343-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023022269", 
          "https://doi.org/10.1007/s40262-015-0343-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc09-2260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023875813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.regpep.2010.05.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025695747"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-0126-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027135938", 
          "https://doi.org/10.1007/s00125-005-0126-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-0126-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027135938", 
          "https://doi.org/10.1007/s00125-005-0126-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-005-0126-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027135938", 
          "https://doi.org/10.1007/s00125-005-0126-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1504720", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027808643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(15)00233-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028492915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)67667-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029064920"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1509225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031621228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1300955", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032234087"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0806470", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034293538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(08)01833-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034787957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199307293290502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037654443"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc05-2415", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037787465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1979.03290450033020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039695204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000115118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043546536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.52.7.1786", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043561983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-016-0155-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043791649", 
          "https://doi.org/10.1007/s13300-016-0155-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)12948-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049195365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)12948-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049195365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00394-016-1212-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049660784", 
          "https://doi.org/10.1007/s00394-016-1212-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00394-016-1212-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049660784", 
          "https://doi.org/10.1007/s00394-016-1212-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2008.10.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049825658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cmet.2016.06.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051656989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circresaha.116.306923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052062354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circresaha.116.306923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052062354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.241.19.2035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054137527"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/acs.jmedchem.5b00726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055099549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/en.2003-0323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064246113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/en.2011-1443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064251130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2010-2081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064292445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2010-2822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064292606"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/0000115118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077599642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078315279", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m117.779496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084153234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4158/ep171764.appgl", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085053730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4158/ep171764.appgl", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085053730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.13028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085746677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1611925", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085993372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08741-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091267078", 
          "https://doi.org/10.1038/s41598-017-08741-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08741-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091267078", 
          "https://doi.org/10.1038/s41598-017-08741-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08741-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091267078", 
          "https://doi.org/10.1038/s41598-017-08741-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.028136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091433107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.117.028136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091433107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1612917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091785136"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(17)30412-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099603046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(17)30412-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099603046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc17-0417", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099683193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30024-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100768864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10557-018-6773-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101033651", 
          "https://doi.org/10.1007/s10557-018-6773-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2018.03.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104511734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.13487", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105965334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.13487", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105965334"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-11", 
    "datePublishedReg": "2018-11-01", 
    "description": "PURPOSE OF REVIEW: Mimetics and analogs that extend the half-life of native glucagon-like peptide-1 (GLP-1), i.e., glucagon-like peptide-1 receptor agonists (GLP-1 RAs), at therapeutic doses, are indicated as adjuncts to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus (T2DM). In patients with T2DM, GLP-1 RAs not only affect improvements in impaired beta cell and alpha cell function, suppress appetite, and induce weight loss but also possess multiple cardiovascular protective properties that potentially have a beneficial impact on atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality.\nRECENT FINDINGS: Required to demonstrate CV safety, compared to standard-of-care antidiabetic therapies, GLP-1 RAs have revealed statistically significant non-inferiority (p\u2009<\u20090.001), among CV outcome trials (CVOTs) thus far completed. Once-daily liraglutide and once-weekly semaglutide demonstrated significant superiority (p\u2009=\u20090.01 and p\u2009=\u20090.02, respectively), reducing 3-point composite major adverse cardiovascular events (MACE) in extreme risk secondary prevention adults with T2DM. Once-weekly exenatide demonstrated only a non-significant (p\u2009=\u20090.06) favorable trend for CV superiority, possibly due to in-trial mishaps, including placebo drop-ins with other CV protective medications. The short half-life lixisenatide was neutral (p\u2009=\u20090.81) in reducing MACE, most likely due to ineffective once-daily dosing. Structural differences among GLP-1 mimetics and analogs may explain potency differences in both A1C reduction and weight loss that may parallel important cardiovascular protective properties of the GLP-1 RA class. Significant superiority in reducing 3-point composite MACE in adults with T2DM with GLP-1 RAs has been limited to liraglutide and semaglutide. Careful attention to within-trial drop-in of cardioprotective antidiabetic agents assuring equipoise between placebo and investigational product groups might demonstrate significant MACE risk reduction with once-weekly exenatide. Maintenance of 24-h circulating levels, by an alternative administration method, may resurrect lixisenatide as a cardioprotective agent. Before a GLP-1 RA bioequivalence \"class effect\" claim for composite MACE risk reduction superiority can be fully discussed, we are obliged to wait for the pending results of CVOTs with other GLP-1 RAs, particularly albiglutide and dulaglutide, where steric hindrance may potentially inhibit full mimicry of pharmacologic GLP-1.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11886-018-1051-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021175", 
        "issn": [
          "1523-3782", 
          "1534-3170"
        ], 
        "name": "Current Cardiology Reports", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "name": "Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?", 
    "pagination": "113", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "128519c754bd3696d278948e469cd93a1279e4a17ac7c020dd2c84cf811a04db"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30259238"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100888969"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11886-018-1051-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107253109"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11886-018-1051-2", 
      "https://app.dimensions.ai/details/publication/pub.1107253109"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T13:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000569.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11886-018-1051-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11886-018-1051-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11886-018-1051-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11886-018-1051-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11886-018-1051-2'


 

This table displays all metadata directly associated to this object as RDF triples.

261 TRIPLES      21 PREDICATES      87 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11886-018-1051-2 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N3011a99e778943b2a33b6c3d75d9c48c
4 schema:citation sg:pub.10.1007/s00125-005-0126-y
5 sg:pub.10.1007/s00394-016-1212-2
6 sg:pub.10.1007/s10557-018-6773-2
7 sg:pub.10.1007/s11883-003-0033-y
8 sg:pub.10.1007/s13300-016-0155-1
9 sg:pub.10.1007/s40262-015-0343-6
10 sg:pub.10.1007/s40265-015-0370-5
11 sg:pub.10.1038/nrendo.2012.140
12 sg:pub.10.1038/s41598-017-08741-0
13 https://app.dimensions.ai/details/publication/pub.1078315279
14 https://doi.org/10.1001/jama.1979.03290450033020
15 https://doi.org/10.1001/jama.241.19.2035
16 https://doi.org/10.1001/jama.288.23.2998
17 https://doi.org/10.1016/j.ahj.2018.03.030
18 https://doi.org/10.1016/j.amjcard.2008.10.002
19 https://doi.org/10.1016/j.cmet.2016.06.009
20 https://doi.org/10.1016/j.regpep.2010.05.008
21 https://doi.org/10.1016/s0002-9149(08)01833-x
22 https://doi.org/10.1016/s0140-6736(03)12948-0
23 https://doi.org/10.1016/s0140-6736(05)67667-2
24 https://doi.org/10.1016/s0140-6736(12)61267-7
25 https://doi.org/10.1016/s0140-6736(14)60976-4
26 https://doi.org/10.1016/s0140-6736(98)07019-6
27 https://doi.org/10.1016/s2213-8587(15)00233-8
28 https://doi.org/10.1016/s2213-8587(17)30412-6
29 https://doi.org/10.1016/s2213-8587(18)30024-x
30 https://doi.org/10.1021/acs.jmedchem.5b00726
31 https://doi.org/10.1053/j.gastro.2008.01.017
32 https://doi.org/10.1056/nejm199307293290502
33 https://doi.org/10.1056/nejmoa0806470
34 https://doi.org/10.1056/nejmoa1107579
35 https://doi.org/10.1056/nejmoa1300955
36 https://doi.org/10.1056/nejmoa1504720
37 https://doi.org/10.1056/nejmoa1509225
38 https://doi.org/10.1056/nejmoa1603827
39 https://doi.org/10.1056/nejmoa1607141
40 https://doi.org/10.1056/nejmoa1611925
41 https://doi.org/10.1056/nejmoa1612917
42 https://doi.org/10.1074/jbc.m117.779496
43 https://doi.org/10.1111/dom.13028
44 https://doi.org/10.1111/dom.13487
45 https://doi.org/10.1136/bmj.321.7258.405
46 https://doi.org/10.1159/0000115118
47 https://doi.org/10.1159/000115118
48 https://doi.org/10.1161/circresaha.115.306249
49 https://doi.org/10.1161/circresaha.116.306923
50 https://doi.org/10.1161/circulationaha.117.028136
51 https://doi.org/10.1210/en.2003-0323
52 https://doi.org/10.1210/en.2011-1443
53 https://doi.org/10.1210/jc.2010-2081
54 https://doi.org/10.1210/jc.2010-2822
55 https://doi.org/10.2337/db09-9028
56 https://doi.org/10.2337/dc05-2415
57 https://doi.org/10.2337/dc09-2260
58 https://doi.org/10.2337/dc17-0417
59 https://doi.org/10.2337/diabetes.52.7.1786
60 https://doi.org/10.2337/diabetes.53.9.2492
61 https://doi.org/10.4158/ep171764.appgl
62 schema:datePublished 2018-11
63 schema:datePublishedReg 2018-11-01
64 schema:description PURPOSE OF REVIEW: Mimetics and analogs that extend the half-life of native glucagon-like peptide-1 (GLP-1), i.e., glucagon-like peptide-1 receptor agonists (GLP-1 RAs), at therapeutic doses, are indicated as adjuncts to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus (T2DM). In patients with T2DM, GLP-1 RAs not only affect improvements in impaired beta cell and alpha cell function, suppress appetite, and induce weight loss but also possess multiple cardiovascular protective properties that potentially have a beneficial impact on atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality. RECENT FINDINGS: Required to demonstrate CV safety, compared to standard-of-care antidiabetic therapies, GLP-1 RAs have revealed statistically significant non-inferiority (p < 0.001), among CV outcome trials (CVOTs) thus far completed. Once-daily liraglutide and once-weekly semaglutide demonstrated significant superiority (p = 0.01 and p = 0.02, respectively), reducing 3-point composite major adverse cardiovascular events (MACE) in extreme risk secondary prevention adults with T2DM. Once-weekly exenatide demonstrated only a non-significant (p = 0.06) favorable trend for CV superiority, possibly due to in-trial mishaps, including placebo drop-ins with other CV protective medications. The short half-life lixisenatide was neutral (p = 0.81) in reducing MACE, most likely due to ineffective once-daily dosing. Structural differences among GLP-1 mimetics and analogs may explain potency differences in both A1C reduction and weight loss that may parallel important cardiovascular protective properties of the GLP-1 RA class. Significant superiority in reducing 3-point composite MACE in adults with T2DM with GLP-1 RAs has been limited to liraglutide and semaglutide. Careful attention to within-trial drop-in of cardioprotective antidiabetic agents assuring equipoise between placebo and investigational product groups might demonstrate significant MACE risk reduction with once-weekly exenatide. Maintenance of 24-h circulating levels, by an alternative administration method, may resurrect lixisenatide as a cardioprotective agent. Before a GLP-1 RA bioequivalence "class effect" claim for composite MACE risk reduction superiority can be fully discussed, we are obliged to wait for the pending results of CVOTs with other GLP-1 RAs, particularly albiglutide and dulaglutide, where steric hindrance may potentially inhibit full mimicry of pharmacologic GLP-1.
65 schema:genre research_article
66 schema:inLanguage en
67 schema:isAccessibleForFree false
68 schema:isPartOf N0c6ec4c532eb4fef8d51eac75ce19231
69 N47c6e313adce4e6399573fd3b0a789e8
70 sg:journal.1021175
71 schema:name Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
72 schema:pagination 113
73 schema:productId N222096179f3240b1be6e39af4cfc2ac6
74 N79f685f234d74f098fd21ba82675a9e6
75 Nb26ea9ebb66c4e09a9cde7199ae78e8e
76 Nb6e32f8bacca48d5bdc6b93d20872b7c
77 Nea6fcf08d2294776816f02b11c9c9e5f
78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107253109
79 https://doi.org/10.1007/s11886-018-1051-2
80 schema:sdDatePublished 2019-04-10T13:27
81 schema:sdLicense https://scigraph.springernature.com/explorer/license/
82 schema:sdPublisher Na4b8b65911294da598a334d97406210c
83 schema:url https://link.springer.com/10.1007%2Fs11886-018-1051-2
84 sgo:license sg:explorer/license/
85 sgo:sdDataset articles
86 rdf:type schema:ScholarlyArticle
87 N0c6ec4c532eb4fef8d51eac75ce19231 schema:volumeNumber 20
88 rdf:type schema:PublicationVolume
89 N1b2127910917447eab3f0fa039b853e6 rdf:first sg:person.01151445632.61
90 rdf:rest rdf:nil
91 N222096179f3240b1be6e39af4cfc2ac6 schema:name nlm_unique_id
92 schema:value 100888969
93 rdf:type schema:PropertyValue
94 N2d640eb9f8a446048c31f852d6eaf61f schema:affiliation N86a9c1154f1642d5aa42315c65767903
95 schema:familyName Li
96 schema:givenName Yixing
97 rdf:type schema:Person
98 N3011a99e778943b2a33b6c3d75d9c48c rdf:first N2d640eb9f8a446048c31f852d6eaf61f
99 rdf:rest N1b2127910917447eab3f0fa039b853e6
100 N47c6e313adce4e6399573fd3b0a789e8 schema:issueNumber 11
101 rdf:type schema:PublicationIssue
102 N79f685f234d74f098fd21ba82675a9e6 schema:name readcube_id
103 schema:value 128519c754bd3696d278948e469cd93a1279e4a17ac7c020dd2c84cf811a04db
104 rdf:type schema:PropertyValue
105 N86a9c1154f1642d5aa42315c65767903 schema:name West Anaheim Medical Center, Department of Medicine, OPTI-West, 3033 West Orange Ave, 92804, Anaheim, CA, USA
106 rdf:type schema:Organization
107 Na4b8b65911294da598a334d97406210c schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 Nb26ea9ebb66c4e09a9cde7199ae78e8e schema:name pubmed_id
110 schema:value 30259238
111 rdf:type schema:PropertyValue
112 Nb6e32f8bacca48d5bdc6b93d20872b7c schema:name dimensions_id
113 schema:value pub.1107253109
114 rdf:type schema:PropertyValue
115 Nea6fcf08d2294776816f02b11c9c9e5f schema:name doi
116 schema:value 10.1007/s11886-018-1051-2
117 rdf:type schema:PropertyValue
118 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
119 schema:name Medical and Health Sciences
120 rdf:type schema:DefinedTerm
121 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
122 schema:name Clinical Sciences
123 rdf:type schema:DefinedTerm
124 sg:journal.1021175 schema:issn 1523-3782
125 1534-3170
126 schema:name Current Cardiology Reports
127 rdf:type schema:Periodical
128 sg:person.01151445632.61 schema:affiliation https://www.grid.ac/institutes/grid.417319.9
129 schema:familyName Rosenblit
130 schema:givenName Paul D.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151445632.61
132 rdf:type schema:Person
133 sg:pub.10.1007/s00125-005-0126-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1027135938
134 https://doi.org/10.1007/s00125-005-0126-y
135 rdf:type schema:CreativeWork
136 sg:pub.10.1007/s00394-016-1212-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049660784
137 https://doi.org/10.1007/s00394-016-1212-2
138 rdf:type schema:CreativeWork
139 sg:pub.10.1007/s10557-018-6773-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101033651
140 https://doi.org/10.1007/s10557-018-6773-2
141 rdf:type schema:CreativeWork
142 sg:pub.10.1007/s11883-003-0033-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1022396275
143 https://doi.org/10.1007/s11883-003-0033-y
144 rdf:type schema:CreativeWork
145 sg:pub.10.1007/s13300-016-0155-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043791649
146 https://doi.org/10.1007/s13300-016-0155-1
147 rdf:type schema:CreativeWork
148 sg:pub.10.1007/s40262-015-0343-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023022269
149 https://doi.org/10.1007/s40262-015-0343-6
150 rdf:type schema:CreativeWork
151 sg:pub.10.1007/s40265-015-0370-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004781251
152 https://doi.org/10.1007/s40265-015-0370-5
153 rdf:type schema:CreativeWork
154 sg:pub.10.1038/nrendo.2012.140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011731640
155 https://doi.org/10.1038/nrendo.2012.140
156 rdf:type schema:CreativeWork
157 sg:pub.10.1038/s41598-017-08741-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091267078
158 https://doi.org/10.1038/s41598-017-08741-0
159 rdf:type schema:CreativeWork
160 https://app.dimensions.ai/details/publication/pub.1078315279 schema:CreativeWork
161 https://doi.org/10.1001/jama.1979.03290450033020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039695204
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1001/jama.241.19.2035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054137527
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1001/jama.288.23.2998 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000553070
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/j.ahj.2018.03.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104511734
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1016/j.amjcard.2008.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049825658
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1016/j.cmet.2016.06.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051656989
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1016/j.regpep.2010.05.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025695747
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/s0002-9149(08)01833-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034787957
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/s0140-6736(03)12948-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049195365
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/s0140-6736(05)67667-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029064920
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/s0140-6736(12)61267-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020847124
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/s0140-6736(14)60976-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019874547
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/s0140-6736(98)07019-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018881858
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/s2213-8587(15)00233-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028492915
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/s2213-8587(17)30412-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099603046
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s2213-8587(18)30024-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1100768864
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1021/acs.jmedchem.5b00726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055099549
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1053/j.gastro.2008.01.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007348653
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1056/nejm199307293290502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037654443
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1056/nejmoa0806470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034293538
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1056/nejmoa1107579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021736323
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1056/nejmoa1300955 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032234087
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1056/nejmoa1504720 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027808643
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1056/nejmoa1509225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031621228
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1056/nejmoa1603827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010225149
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1056/nejmoa1607141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001940001
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1056/nejmoa1611925 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085993372
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1056/nejmoa1612917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091785136
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1074/jbc.m117.779496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084153234
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1111/dom.13028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085746677
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1111/dom.13487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105965334
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1136/bmj.321.7258.405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000154862
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1159/0000115118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077599642
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1159/000115118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043546536
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1161/circresaha.115.306249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014793790
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1161/circresaha.116.306923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052062354
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1161/circulationaha.117.028136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091433107
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1210/en.2003-0323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064246113
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1210/en.2011-1443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064251130
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1210/jc.2010-2081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064292445
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1210/jc.2010-2822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064292606
242 rdf:type schema:CreativeWork
243 https://doi.org/10.2337/db09-9028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004893088
244 rdf:type schema:CreativeWork
245 https://doi.org/10.2337/dc05-2415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037787465
246 rdf:type schema:CreativeWork
247 https://doi.org/10.2337/dc09-2260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023875813
248 rdf:type schema:CreativeWork
249 https://doi.org/10.2337/dc17-0417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099683193
250 rdf:type schema:CreativeWork
251 https://doi.org/10.2337/diabetes.52.7.1786 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043561983
252 rdf:type schema:CreativeWork
253 https://doi.org/10.2337/diabetes.53.9.2492 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022950121
254 rdf:type schema:CreativeWork
255 https://doi.org/10.4158/ep171764.appgl schema:sameAs https://app.dimensions.ai/details/publication/pub.1085053730
256 rdf:type schema:CreativeWork
257 https://www.grid.ac/institutes/grid.417319.9 schema:alternateName University of California, Irvine Medical Center
258 schema:name Dept. of Medicine, Div. Endocrinology, Diabetes & Metabolism, University California, Irvine, School of Medicine, Irvine, CA, USA
259 Diabetes / Lipid Management & Research Center, 18821 Delaware St., Suite 202, 92648, Huntington Beach, CA, USA
260 Diabetes Out-Patient Clinic, UCI Medical Center, Orange, CA, USA
261 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...